Graduate of a prestigious university

Once it became clear to Václav Matoušek that the world of chemistry was his place in life, he applied for the University of Chemistry and Technology Prague. Thanks to the Erasmus exchange program, he spent seven months at ETH Zürich, the seventh best university in the world. In addition to the regular seminars, he worked in laboratories and worked on catalysis research led by Dr. Pavel Kukula.

Even though his studies in Zurich were far from easy, Matoušek asked two local professors to let him return to ETH for his doctorate studies. “At the time, I was only a third-year student, so it may have seemed a bit premature, but it paid off,” adds Matoušek.

Surprising discovery

In 2009, Matoušek joined the team of Professor Antonio Togni who had discovered a unique compound a few years before. The discovery seemed to be more of an academic interest at first, so Togni only published it and did not seek a patent for the compound class. Gradually, though, scientific magazines all over the world published more and more articles describing it as a very useful tool.

Only several years later was this compound nicknamed Togni’s reagent, which has become a commonly-used term ever since.

Togni’s reagents are compounds based on hypervalent iodine, which behave like tools transferring fluorine groups. Fluorine has become a very sought-after tool, especially in pharmaceuticals, where it improves the effectiveness of drugs: “Thirty years ago, only around 5 % of drugs on the market contained fluorine, whereas today it’s around 20 % and rising with each newly-registered drug. We’ve been seeing a huge increase in the use of fluorine in the design of new molecules to treat diseases,” explains Matoušek.

 “Matoušek-Beier-Togni reagents”

In 2010, when Matoušek was halfway through his studies at ETH, it was already apparent that Togni’s reagents were highly useful tools. Once, while reading a chemistry magazine, an exciting idea occurred to him: “I came across an article by Dr. Petr Beier from the Czech Academy of Sciences; what he said in the article inspired me to join forces with him to create a brand new generation of Togni’s reagents. Unlike the original ones, these would have a large structural variability. This would allow us to modify the character of the fluorinated groups, which is the main part of the entire molecule, effectively increasing the structural richness of the reagents.


After several unsuccessful attempts, Matoušek and his Czech colleagues finally succeeded in isolating a small amount of something new. The following tests verified that he actually synthesized a second-generation Togni’s reagent and thus opened the door to a brand new area in chemistry – to a set of available chemical structures that can be produced – and thus to new opportunities.

In 2014, ETH applied to patent second-generation Togni’s reagents at the Swiss patent authority: “In 2010, there were already around a hundred publications describing the excellent usability of the first-generation reagents, so it was apparent that it would work in generation No. 2 as well,” adds Matoušek. Together with filing the application, ETH suggested that Matoušek, as the main inventor, should participate in the process of commercialising the new technology.

Irresistible offer from #brnoregion

Despite being a chemist at heart, Matoušek eventually abandoned the original idea to continue his studies after obtaining his PhD. He decided to accept the challenge and cash in on his discovery: “It was an amazing opportunity to pass something I’ve invented on to the rest of the world.” The only question was where and what for.

And an offer from Brno arrived at the right moment: “Jindra Weiss, one of my high-school classmates working at the South Moravian Innovation Centre at the time, suggested to me: ‘Václav, come join us in Brno. You’ll get a lab and will work with us’.” Matoušek didn’t have to think about it for long. True, he comes from South Bohemia, but #brnoregion is definitely closer to his home than Switzerland. ETH donated him some outdated equipment and with it he built up a small lab at the INBIT centre in Brno in 2014 and established CF Plus Chemicals.

JIC INBIT is a biotechnology incubator in #brnoregion that helps deal with the lack of affordable space for innovation businesses in the region of South Moravia. Companies in the incubator are located close to the laboratories of Masaryk University and the University Hospital Brno as well, which facilitates their potential cooperation with research institutes. 

Unique compounds for further research

As Matoušek established the company on his own, he had to learn a lot of things related to the lab equipment, purchasing chemicals, basic accounting, and later marketing and sales. He started to synthetize the first compounds in 2015 and his contacts from Switzerland helped him get his first orders. Things started out slowly, but suddenly an unknown customer from Austria appeared: “I still remember that intoxicating feeling. For me, it was proof that I could actually sell something,” remembers Matoušek.

The name CF Plus Chemicals is based on CF2CF, which is a bond of carbon and fluorine and their connection to other molecules.

Currently, CF Plus Chemicals produces all the substances in its lab and production volumes do not exceed one kilogram because they are used mainly for research. If they turn out to be as efficient as Matoušek promises, that figure will increase quickly.

Expert on fluoroalkylation and bioconjugation

Currently, CF Plus Chemicals sells its substances primarily to pharmaceutical companies and academic laboratories that create and test new types of small molecules. These were previously quite difficult to prepare and Matoušek’s reagents save them a lot of time.

What’s more important for Matoušek is the production of reagents for the discovery and development of large molecule-based drugs, especially protein drugs. They either serve for preparation of protein conjugates, compounds where proteins are chemically connected with other functional substances (i.e. toxins or radioactive compounds to kill cancer cells, fluorescent dyes for imaging, etc.) or they can be used to effectively study the structure of the proteins. In the future, this will make protein drugs more efficient when fighting chronic diseases, such as cancer and diabetes.

Drugs are divided into two abstract categories. The drugs made of small molecules are historically older and usually put into tablets, ointments, suppositories or inhalers. Since the 1960s, drugs based on proteins, also called large molecules, have been entering the market. The most well-known is perhaps insulin, but lately modern targeted drugs based on antibodies and their conjugates have been used more frequently, mainly in oncology. And oncology is one of the main areas into which Matoušek would like to move with his technology.

This way, CF Plus Chemicals could help resolve a number of the challenges pharmaceutical and biopharmaceutical companies face, as Matoušek can both propose a solution and give advice on what works. “Even though our reagents are new and still relatively unknown, it’s my task to convince pharmaceutical companies that they work perfectly, quickly, and reliably and that they can be used to prepare new, previously inaccessible molecules or enable technologies that used to be impossible,” explains Matoušek.



The aim is to divide the company into two segments – one focusing on the production of reagents and building blocks for synthesis of small molecule drug candidates, and the other dealing with large molecule bioconjugation through license agreements: “For the segment of small molecules, I’d like to have a portfolio of five hundred to one thousand substances. In addition, I’ve prepared a concept of around five to ten second generation Togni’s reagents whose reactivity can be adjusted and which will be amenable to large scale synthesis, being able to serve the needs of the large molecule bioconjugation segment,” says Matoušek about his plans for the future.

"If one day some of the drugs containing the —CF2CF2— group from the Togni’s reagent appear in the top 200 best-selling drugs, that will be the greatest satisfaction for professor Togni and myself. Once we see that, for example, the twelfth best-selling substance comes from this original idea, our lives as chemists will be complete."

28. 05. 2019
Photos: CF Plus Chemicals

More articles

Madfinger Games Do Business

Madfinger Games

The urge to do things their own way has placed Madfinger Games, a studio developing games for mobile phones, among the very best in the world. Titles such as Samurai, Shadowgun and... Read more
World from Space Do Business

World from Space

It all started with two excited postgraduate students and an unrealistic dream of using the data from outer space. Today, however, World from Space is a company which helps communi... Read more
LIKO-S Do Business

LIKO-S

They’ve built the first green production hall in the world and thus became experts on green roofs and walls. LIKO-S is one of the largest European producers of interior partitions,... Read more
Survio Do Business

Survio

In 2007, Ondřej Coufalík and Martin Pavlíček established a predecessor of today’s survey platform Survio. It’s been a long, bumpy road, but now over 2 million users from all over t... Read more
Safetica Technologies Do Business

Safetica Technologies

Companies in over 95 countries protect their data using the Safetica DLP program from #brnoregion. Read more
Bender Robotics Do Business

Bender Robotics

“If you can put electronics into it, our company can make it.” Stanislav Věchet Read more
A good address for innovation business Do Business

A good address for innovation business

More and more people are calling #brnoregion a Metropolis of Science, the centre of research and development, and a great place for all the active people whose ideas change the wor... Read more
SAP Labs Czech Republic Do Business

SAP Labs Czech Republic

“We want people to always associate finance and SAP enterprise application software with Brno. That’s our vision for the future,” says Martin Janáček, MD at SAP Labs Czech Republic... Read more
Kentico Software Do Business

Kentico Software

“From Day 1, I wanted to do business on an international level and sell software all over the world. That’s one of the reasons our very first customer was from the USA,” says Petr ... Read more
Jiří Očadlík Do Business

Jiří Očadlík

"If people don’t come together, new quality will never be created" Read more
DATAWEPS Do Business

DATAWEPS

“If you are a customer and buy products in online stores, then you come across our services without even knowing it. And if you are a retailer or a producer selling products online... Read more
NenoVision Do Business

NenoVision

“It was incredibly hard to imagine that this weird thing (which hadn’t been working properly yet) would one day become an actual product and work perfectly. That people would buy i... Read more
We support entrepreneurial spirit! Do Business

We support entrepreneurial spirit!

A secondary school leaving certificate, or a university degree is a great achievement for most students. They ploughed through their studies, they sailed through the tests, they ar... Read more
FLOWMON Do Business

FLOWMON

„What was originally an academic spin-off has become a successful global company, helping protect computer networks against cybernetic threats and DDoS attacks in over 35 countries... Read more
Bastl Instruments Do Business

Bastl Instruments

“Czechs should be proud of their DIY past. The effort to restore respect for it and make the best of this heritage was the driving force of our business,” says Ondřej Merta, the CE... Read more
Czech Republic spearheads speech research Do Business

Czech Republic spearheads speech research

“We were there at the inception of this success. Customers all over the world use our technologies,” says Petr Schwarz, the founder and current CTO of Phonexia. Read more
Would you like to start your business? Do Business

Would you like to start your business?

Great to hear! In that case you could use these 10 brief advices. Read more
WHY INVEST IN #BRNOREGION Do Business

WHY INVEST IN #BRNOREGION

RedHat, Honeywell, or NetSuite. And Kiwi, Y Soft, or Safetica. These are very successful companies based in Brno. The list of leaders and their achievements is much longer and beyo... Read more
GREYCORTEX – A startup? Yes and no Do Business

GREYCORTEX – A startup? Yes and no

Even though GREYCORTEX celebrated only two years of existence in May, the work on its main product started a long time before. In the area of Internet security, GREYCORTEX are lead... Read more
Sewio Networks: With a sense of wireless Do Business

Sewio Networks: With a sense of wireless

“We recognized the potential of wireless technologies in Industry 4.0 in time, so our sensors – among other things – help improve safety in factories.” Read more
KIWI.com: A rocket from #brnoregion Do Business

KIWI.com: A rocket from #brnoregion

​“How to handle our rapid growth – that’s the biggest challenge we’ve had to face. Currently, we have almost one thousand employees in the Czech Republic, and together with their c... Read more
GINA SOFTWARE Do Business

GINA SOFTWARE

„We have sped up the arrival of fire fighters and rescuers in up to a third of accidents. Through us they can share important information, communicate effectively and coordinate th... Read more
#brnoregion is a startup paradise Do Business

#brnoregion is a startup paradise

#brnoregion is undoubtedly a startup paradise, as shown not only by its 200+ existing active startups, but also by the 2019 Startup Ecosystem Rankings Report which has marked Czech... Read more
This website uses cookies to ensure you get the best experience on our website. Learn more